Integrity Applications has developed a non-invasive blood glucose monitor.

The device utilizes a patented combination of ultrasonic, electromagnetic and thermal technologies to measure three distinct criteria to provide an accurate blood glucose measurement.

GlucoTrack enables diabetics (Type 1 and 2)  to measure their blood glucose levels without drawing blood. A small sensor clips comfortably to the ear lobe while blood glucose level is calculated using a proprietary algorithm and displayed on a companion small, portable unit which can be fastened to one's belt.

GlucoTrack removes the two most significant barriers to frequent monitoring of blood glucose by diabetics: pain (the device is non-invasive) and cost (no disposables required). GlucoTrack is able to measure blood glucose both at discrete moments (Spot Measurement) and on a continuous basis (in next generation devices), making it the right solution for a wide range of diabetic patients.

All diabetics would benefit from a device that does not require them to prick their finger or draw blood, and caregivers for premature infants, pediatric and elderly patients will also immediately recognize the importance and appeal of the device's non-invasive nature.

Integrity Applications' prototype, Alpha and Beta site devices of GlucoTrack have been proven safe and effective for patients in practical tests, conducted under the supervision of leading diabetes authorities at the Soroka University Medical Center. Integrity Applications is preparing to bring GlucoTrack to the market in  2012.

Integrity Applications Ltd. is based in Ashkelon, Israel. Founders and employees bring a wide range of engineering, technology background, design and management skills to the company. 

Form 10-Q for the Quarter Ended September 30, 2011: Interactive Data Files